Medicines Australia Limited - Revocation and Substitution - A91316 - A91320

Outcome	Granted
Applicant(s)	Medicines Australia Limited
Authorisation number(s)/Date lodged	A91316, 4^th July 2012 A91317, 4^th July 2012 A91318, 4^th July 2012 A91319, 4^th July 2012 A91320, 4^th July 2012
Summary	On 4 July 2012 Medicines Australia Limited applied for reauthorisation (application for revocation and substitution) for its Code of Conduct Edition 17. The Code of Conduct sets standards for the advertising and promotion of pharmaceutical products. On 20 December 2012 the ACCC issued a determination granting reauthorisation for a period of two years. A copy of the ACCC's determination is available by following the links below.
Documents	Applications ACCC correspondence Submissions Pre-decision conference ACCC decisions
Related media releases	ACCC calls on Medicines Australia to improve disclosure of payments to individual healthcare professionals The ACCC has given pharmaceutical companies that are members of Medicines Australia two years to ... Issued: 20^th December 2012 Release # NR 278/12

Browse authorisations

About public registers

Notify me...